INNOCAN PHARMA Corp
INNPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $52,456 | $22,794 | $37,365 | $44,344 |
| - Cash | $7,270 | $7,255 | $6,365 | $5,008 |
| + Debt | $1,523 | $1,397 | $1,302 | $10 |
| Enterprise Value | $46,709 | $16,936 | $32,302 | $39,346 |
| Revenue | $6,746 | $7,006 | $7,796 | $5,401 |
| % Growth | -3.7% | -10.1% | 44.3% | – |
| Gross Profit | $6,122 | $6,195 | $7,115 | $4,409 |
| % Margin | 90.8% | 88.4% | 91.3% | 81.6% |
| EBITDA | -$1,405 | -$96 | $46 | $12 |
| % Margin | -20.8% | -1.4% | 0.6% | 0.2% |
| Net Income | -$1,947 | -$590 | -$582 | -$114 |
| % Margin | -28.9% | -8.4% | -7.5% | -2.1% |
| EPS Diluted | -0.43 | -0.13 | -0.13 | -0.026 |
| % Growth | -230.8% | 0% | -400% | – |
| Operating Cash Flow | $22 | $686 | $368 | -$504 |
| Capital Expenditures | -$4 | -$1 | -$5 | -$4 |
| Free Cash Flow | $18 | $685 | $363 | -$508 |